Caprock Group LLC Sells 258 Shares of Tenet Healthcare Co. (NYSE:THC)

Caprock Group LLC decreased its holdings in Tenet Healthcare Co. (NYSE:THC) by 6.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,664 shares of the company’s stock after selling 258 shares during the period. Caprock Group LLC’s holdings in Tenet Healthcare were worth $463,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in THC. FMR LLC boosted its holdings in shares of Tenet Healthcare by 88.0% during the third quarter. FMR LLC now owns 7,700,693 shares of the company’s stock worth $1,279,855,000 after acquiring an additional 3,604,161 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Tenet Healthcare by 23.6% during the third quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock worth $339,893,000 after acquiring an additional 390,316 shares during the period. Iron Triangle Partners LP bought a new stake in shares of Tenet Healthcare during the third quarter worth approximately $51,346,000. Allspring Global Investments Holdings LLC boosted its holdings in shares of Tenet Healthcare by 344.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 317,198 shares of the company’s stock worth $52,718,000 after acquiring an additional 245,875 shares during the period. Finally, Point72 Asset Management L.P. increased its holdings in shares of Tenet Healthcare by 32.0% during the third quarter. Point72 Asset Management L.P. now owns 442,949 shares of the company’s stock worth $73,618,000 after purchasing an additional 107,290 shares during the period. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Trading Down 0.5 %

THC opened at $143.91 on Wednesday. Tenet Healthcare Co. has a fifty-two week low of $86.70 and a fifty-two week high of $171.20. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.58 and a quick ratio of 1.52. The firm has a market capitalization of $13.69 billion, a price-to-earnings ratio of 4.61, a PEG ratio of 0.63 and a beta of 2.05. The company’s 50 day moving average price is $133.98 and its two-hundred day moving average price is $148.64.

Analyst Upgrades and Downgrades

THC has been the topic of several recent research reports. UBS Group raised their target price on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a report on Wednesday, October 30th. Wells Fargo & Company cut shares of Tenet Healthcare from an “overweight” rating to an “equal weight” rating and lowered their target price for the stock from $205.00 to $150.00 in a report on Monday, November 25th. Royal Bank of Canada raised their target price on shares of Tenet Healthcare from $174.00 to $183.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Cantor Fitzgerald upped their price target on shares of Tenet Healthcare from $168.00 to $177.00 and gave the stock an “overweight” rating in a report on Wednesday, October 30th. Finally, Raymond James downgraded shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target for the company. in a report on Friday, November 22nd. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $165.00.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.